242
Participants
Start Date
August 7, 2018
Primary Completion Date
October 23, 2023
Study Completion Date
October 23, 2023
Brazikumab
Intravenous brazikumab on day 1, day 15, and day 43 followed by Subcutaneous brazikumab every 4 weeks beginning on day 71 through Week 50
Placebo
Intravenous placebo on day 1, day 15, and day 43 followed by Subcutaneous placebo every 4 weeks beginning on Day 71 through Week 50.
Research Site, Taipei
Research Site, Debrecen
Research Site, Cape Town
Research Site, Cape Town
Research Site, Plumstead
Research Site, Bloemfontein
Research Site, New York
Research Site, Sunnyside
Research Site, Uniontown
Research Site, Rho
Research Site, Milan
Research Site, Hamburg
Research Site, Vinnytsia
Research Site, North Chesterfield
Research Site, Kiel
Research Site, Wŏnju
Research Site, Morehead City
Research Site, Atlanta
Research Site, Haifa
Research Site, Miami Lakes
Research Site, Miami
Research Site, Miami
Research Site, Tampa
Research Site, Tampa
Research Site, Clearwater
Research Site, Lakeland
Research Site, Naples
Research Site, Inverness
Research Site, New Port Richey
Research Site, Kissimmee
Research Site, Negrar
Research Site, Biloxi
Research Site, Taichung
Research Site, Daegu
Research Site, Beachwood
Research Site, Springfield
Research Site, Valencia
Research Site, Brownsburg
Research Site, Evansville
Research Site, Busan
Research Site, Wyoming
Research Site, Gurnee
Research Site, Oak Lawn
Research Site, Shawnee Mission
Research Site, Topeka
Research Site, Marrero
Research Site, Baton Rouge
Research Site, Shreveport
Research Site, Little Rock
Research Site, Oklahoma City
Research Site, Carrollton
Research Site, Houston
Research Site, Houston
Research Site, Humble
Research Site, Houston
Research Site, San Antonio
Research Site, San Antonio
Research Site, Pflugerville
Research Site, Amarillo
Research Site, Colorado Springs
Research Site, Phoenix
Research Site, Tucson
Research Site, Ulm
Research Site, Las Vegas
Research Site, Las Vegas
Research Site, Mission Hills
Research Site, Chula Vista
Research Site, Poway
Research Site, Lancaster
Research Site, Lincoln
Research Site, New Delhi
Research Site, Moscow
Research Site, Jaipur
Research Site, Rajkot
Research Site, Surat
Research Site, Izhevsk
Research Site, Hyderabad
Research Site, Bangalore
Research Site, Perm
Research Site, Aramil
Research Site, Novosibirsk
Research Site, Tomsk
Research Site, Petah Tikva
Research Site, Jerusalem
Research Site, Chicoutimi
Research Site, Brno
Research Site, České Budějovice
Research Site, Hradec Králové
Research Site, Ostrava
Research Site, Roma
Research Site, Asahikawa-shi
Research Site, Chiba
Research Site, Fukuoka
Research Site, Fukuyama-shi
Research Site, Hakodate-shi
Research Site, Kasama-shi
Research Site, Kashiwa-shi
Research Site, Koshigaya-shi
Research Site, Kure-shi
Research Site, Minatoku
Research Site, Nagaoka-shi
Research Site, Onga-gun
Research Site, Sapporo
Research Site, Takarazuka-shi
Research Site, Bydgoszcz
Research Site, Chojnice
Research Site, Częstochowa
Research Site, Gdansk
Research Site, Krakow
Research Site, Ksawerów
Research Site, Piaseczno
Research Site, Poznan
Research Site, Rzeszów
Research Site, Sopot
Research Site, Torun
Research Site, Warsaw
Research Site, Warsaw
Research Site, Wroclaw
Research Site, San Juan
Research Site, Košice
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Kyiv
Research Site, West Bromwich
Lead Sponsor
AstraZeneca
INDUSTRY